Immuneering Corp — Director's Dealing 2021

Sep 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2021-09-13

Reporting Person: Feinberg Peter (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-13	Class A Common Stock	P	5750	$21.5126	Acquired	392242	Indirect
2021-09-13	Class A Common Stock	P	349	$21.25	Acquired	349	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	476615	Indirect
Class A Common Stock	115441	Indirect

Footnotes

F1: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.08 to $22.00. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.

F2: This transaction was executed in multiple trades through a broker-dealer at a price of $21.25. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.